A Double-Blind, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZE50-0134 in Healthy Volunteers
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs Eiletoclax (Primary) ; Itraconazole
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia
- Focus First in man; Pharmacokinetics
- Sponsors Eilean Therapeutics
- 29 Jan 2025 New trial record